Fertility tests for couples

The ProFertility difference

ProFertility can provide standard fertility testing, but testing is an input rather than the product. We combine questionnaire findings, medical and reproductive history, symptoms and verified results to build a joined-up view of where the pathway may be under strain. From there, we can recommend targeted investigations, create a clinician-approved improvement plan, or escalate for specialist treatment. We also avoid repeating tests that have already answered the question.

Tests commonly used for the female partner

Assessment may include cycle history, appropriately timed hormone tests, pelvic ultrasound and testing for tubal patency. Chlamydia screening may be required before uterine instrumentation or tubal procedures.

AMH or antral follicle count may help estimate ovarian reserve, particularly when planning treatment. They do not measure egg quality directly and should not be interpreted alone as a prediction of natural pregnancy.

Tests commonly used for the male partner

Semen analysis assesses features such as semen volume, sperm concentration, total sperm number, motility and morphology using laboratory methods. If a result is outside the expected range, repeat analysis or further male assessment may be recommended.

Additional tests should be targeted. A semen analysis is important, but it is not a complete assessment of male reproductive health or a guarantee of fertility.

After the results

Results should be interpreted together rather than as isolated red or green flags. A clinician may identify a likely barrier, recommend confirmation or referral, or explain that first-line testing has not found a cause.

The next step may involve optimising health, treating an identified condition, timed expectant management or discussing assisted-conception options. The plan should reflect age, duration of trying, preferences and the strength of evidence for each option.

Why a collection of tests is not yet an assessment

Fertility testing is often sold as a menu: AMH, hormones, ultrasound and semen analysis. The difficulty is that individual results do not automatically explain the couple's fertility pathway. AMH may help estimate ovarian reserve and likely response to stimulation, but it cannot confirm egg quality or predict whether natural conception will occur. A semen result may fall within reference ranges while still needing interpretation alongside duration of trying and female factors.

A joined-up assessment asks a different set of questions. Has ovulation been evaluated appropriately for the person's actual cycle? Is there a reason to assess tubal patency or the uterine cavity? Do symptoms suggest endometriosis or another structural issue? Has the semen sample been produced and analysed correctly, and does the pattern warrant confirmation or male review? Which result would materially change the next decision?

Standard tests and targeted next steps

First-line investigations are valuable because they identify common, important barriers and provide a safe basis for next steps. Additional testing should be selected because the history or existing results create a clinical question, not because more data always means better care. Some commercially available tests measure interesting biology without strong evidence that using the result improves pregnancy or live-birth outcomes.

ProFertility's approach is to separate established findings from possible contributors. We can then prioritise: investigate, optimise, optimise while escalating, or escalate directly. This means a person with a clear tubal problem is not delayed by months of lifestyle advice, while somebody with modifiable health barriers is not rushed into a generic treatment pathway without understanding what can be addressed first.

From results to a six month improvement pathway

Where optimisation is appropriate, results can inform a structured programme rather than a one-off list of recommendations. Actions should be connected to the barrier they are intended to address, reviewed at sensible intervals and changed when progress or new evidence alters the picture. Male and female actions must work together, especially where both partners have contributing factors.

The programme also needs an exit route. At review, the question is whether the barrier has improved, whether further investigation is now justified, whether natural trying remains reasonable or whether treatment should be discussed. That combination of action and escalation is what turns testing into fertility care rather than leaving the customer alone with a report.

How to judge whether a test is worth doing

Before paying for any fertility test, ask four questions: what barrier is it assessing, how reliable is the result, what are its limitations and what would we do differently because of it? If nobody can explain how the answer changes your pathway, the test may create data without creating value. This is especially important for newer investigations and treatment add-ons, where biological plausibility does not always translate into evidence of improved pregnancy or live-birth outcomes.

A strong fertility report should therefore separate facts from interpretation. It should show what has been confirmed, what remains possible, which finding has the greatest impact on time or treatment decisions and which actions are supportive rather than proven to improve outcomes. ProFertility's role is to make that hierarchy visible and turn it into a clinician-approved plan that a patient can actually follow.

What this means for you

The value of testing lies in the decisions it enables. A shorter, well-chosen set of investigations interpreted together can be more useful than an expensive panel that produces no coherent plan. Couples should leave the process knowing which findings matter most, which are reassuring, which need confirmation and what happens if the first plan does not lead to pregnancy. That is the difference between receiving test results and receiving fertility care: the information is connected to actions, review points and a route to escalation, while uncertainty is acknowledged honestly rather than hidden behind more testing.

Frequently asked questions